Delivery Order SPE2DB20D2001-SPE2DB23FM46P
- Not listed
- This federal contract award is for the delivery of Victoza brand pharmaceutical products, specifically 3-paks of 18 mg/3 mL pens, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,310.90 and a completion date of February 3, 2022. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent...
- This federal contract award is for the delivery of Victoza 3-pak 18 mg/3 ml pen 3 ml to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,362.96 award was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract is a firm fixed-price delivery order with an ultimate completion date of October 17, 2023. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $15,737.53, was granted to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA) for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The contract has an ultimate completion date of August 27, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Victoza 3-Pak 18 mg/3 ml Pen 3 ml. The contract has a ceiling value of $3,243.68 and an ultimate completion date of November 1, 2023. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and there is no mention of major...
- This federal contract award is for the delivery of Victoza 3-pak 18 mg/3 ml pen 3 ml to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award has a ceiling value of $3,138.96 and is a firm fixed-price delivery order contract that runs through January 17, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug...
- This federal contract award, valued at $2,118.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including...
- The federal contract award is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 31, 2024 with a ceiling value of $6,356.61. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of November 1, 2024. This award...
- This federal contract award is for the delivery of Victoza 3-Pak 18 mg/3 ml pen 3 ml to the Defense Logistics Agency (DLA). The contract, valued at $12,713.22, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order with a firm fixed price pricing type and has a completion date of February 21, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical...
- This federal contract award, valued at $4,112.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Victoza 3-pak 18 mg/3 ml pen 3 ml, a prescription medication. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
- This federal contract award is for the delivery of Victoza 3-pak 18 mg/3 ml pens to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $2,301.87 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of September 26, 2024 and was awarded on September 25, 2024. This delivery order is part of a larger $999,999,999 Indefinite...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB23FM46PDelivery Order
This federal contract award is for the delivery of the pharmaceutical product Victoza 3-Pak 18 mg/3 ml Pen 3 ml. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a ceiling value of $2,251.87 and an ultimate completion date of March 27, 2023. The contract is a Delivery Order placed against an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 3/24/23 |